* If you want to update the article please login/register
Patients with HCCBCLC stage A, B1, B2, and C with maximum single lesion size of u2264 8 cm and who are not considered suitable for treatment by resection or ablation at the time of study enrollment.
Source link: https://clinicaltrials.gov/ct2/show/NCT04736121
The Screening CECT could be used as the Screening CECT, but it must have been administered in the 24 hours before Consent or After Consent and before randomization. For a total of three doses, patients randomized to Group 2 will receive 1. 0 mg/kg of Auxora intravenously every 24 hours. Patients who were discharged from the hospital before Day 25 will return from the hospital on Day 30 to do the Day 30 assessments. The AGA has a strong preference for early oral feeding rather than keeping the patient nil per mouth in patients with acute pancreatitis. If alert and not on mechanical ventilation, but not on surgical ventilation, or if not NPO for a planned surgey/medical procedure due to an acute medical condition, patients who were randomized into the study will be served a low fat, u2265500-calorie solid meal at every mealtime, or if not NPO for a planned surgey/medical procedure. If the patient does not want to eat the solid meal or is unable to handle the solid meal, they should then be offered a liquid meal. If patients ate u22605 percent of the dish or if they woke up to an abdominal pain in the two hours after eating a meal, it should be noted if they ate u226550% of the dish and if they vomited or experienced an increase in abdominal pain. Tolerating solid food is defined as eating u226550% of a low fat, u2265500-calorie solid meal without an increase in abdominal pain or vomiting.
Source link: https://clinicaltrials.gov/ct2/show/NCT04681066
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions